Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportPoster Presentations - Physicians/Scientists/Pharmacists

Bone marrow dosimetry in peptide receptor radionuclide therapy with [Lu-177-DOTA0,Tyr3]octreotate

Flavio Forrer, Eric Krenning, Peter Kooy, Bert Bernard, Willem Bakker and Dik Kwekkeboom
Journal of Nuclear Medicine May 2006, 47 (suppl 1) 486P;
Flavio Forrer
1Nuclear Medicine , Erasmus MC, Rotterdam , Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric Krenning
1Nuclear Medicine , Erasmus MC, Rotterdam , Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Kooy
1Nuclear Medicine , Erasmus MC, Rotterdam , Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bert Bernard
1Nuclear Medicine , Erasmus MC, Rotterdam , Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Willem Bakker
1Nuclear Medicine , Erasmus MC, Rotterdam , Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dik Kwekkeboom
1Nuclear Medicine , Erasmus MC, Rotterdam , Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 47 no. suppl 1 486P

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online October 30, 2014.

Copyright & Usage 
Society of Nuclear Medicine, Inc.

Author Information

  1. Flavio Forrer1,
  2. Eric Krenning1,
  3. Peter Kooy1,
  4. Bert Bernard1,
  5. Willem Bakker1 and
  6. Dik Kwekkeboom1
  1. 1Nuclear Medicine , Erasmus MC, Rotterdam , Netherlands

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: December 2014 to April 2025

AbstractFullPdf
Dec 2014100
Jan 2015700
Feb 2015100
Apr 2015100
May 2015100
Jul 2015300
Sep 2015300
Jan 2016100
Feb 2016400
Mar 2016100
Jun 2016200
Aug 2016100
Nov 2016100
Dec 2016100
Feb 2017100
Mar 2017200
Apr 2017100
May 2017200
Jul 2017200
Aug 2017200
Sep 2017100
Nov 2017200
Dec 2017200
Jan 2018100
Feb 2018300
Mar 2018100
Jun 2018100
Jul 2018100
Aug 2018100
Nov 2018100
Aug 2019100
Oct 2019100
Feb 2020300
Jul 2020100
Oct 2020200
Nov 2020100
Dec 2020200
Jan 2021300
Feb 2021800
Mar 20211200
Apr 2021800
May 2021700
Jun 2021400
Jul 2021400
Aug 2021200
Sep 2021400
Oct 2021100
Nov 2021500
Dec 2021200
Jan 2022200
Feb 2022300
Mar 2022200
Apr 2022600
May 2022100
Jun 2022100
Jul 2022100
Aug 2022100
Oct 2022100
Nov 2022200
Dec 2022100
Feb 2023300
Mar 2023300
Apr 2023400
May 2023300
Jun 2023200
Jul 2023400
Aug 2023100
Sep 2023400
Oct 2023500
Nov 2023300
Dec 2023600
Jan 2024400
Mar 2024300
Apr 2024100
May 2024400
Jun 20241000
Jul 2024300
Aug 2024700
Sep 2024700
Oct 2024400
Nov 2024300
Dec 2024400
Jan 2025100
Feb 2025300
Apr 2025600
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 47, Issue suppl 1
May 1, 2006
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Bone marrow dosimetry in peptide receptor radionuclide therapy with [Lu-177-DOTA0,Tyr3]octreotate
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Bone marrow dosimetry in peptide receptor radionuclide therapy with [Lu-177-DOTA0,Tyr3]octreotate
Flavio Forrer, Eric Krenning, Peter Kooy, Bert Bernard, Willem Bakker, Dik Kwekkeboom
Journal of Nuclear Medicine May 2006, 47 (suppl 1) 486P;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Bone marrow dosimetry in peptide receptor radionuclide therapy with [Lu-177-DOTA0,Tyr3]octreotate
Flavio Forrer, Eric Krenning, Peter Kooy, Bert Bernard, Willem Bakker, Dik Kwekkeboom
Journal of Nuclear Medicine May 2006, 47 (suppl 1) 486P;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Poster Presentations - Physicians/Scientists/Pharmacists

  • Phase I/II study of Yttrium-90 labeled humanized anti-Tac (HAT) monoclonal antibody and calcium DTPA in adult T-cell leukemia/lymphoma (ATL)
  • PET tumor volume assessment with different CT patient positions in lung cancer
  • Organic and aqueous synthesis of EC-DG for tumor glycolytic activity assessment
Show more Poster Presentations - Physicians/Scientists/Pharmacists

Oncology Track

  • Dual time point FDG-PET-CT imaging in differentiating benign from malignant lung nodules: Our experience in 119 patients
  • Evaluation of thymic epithelial tumors by FDG PET: Correlation with the World Health Organization classification
  • False-negative and false-positive lymph node staging with FDG-PET scan in patients with proven or suspected non-small-cell lung cancer (NSCLC)
Show more Oncology Track

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire